De novo ALL samples revealed approximately 2-fold higher RBP2 mRNA levels than controls, and ALL-relapsed patients had the highest RBP2 mRNA levels (Fig 1C). This evidence concerns the gene RBP2 and acute lymphoblastic leukemia.